C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells

Cat.No.: CSC-C8330W

Species: Mouse

Source: Pancreas

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C8330W
Description
C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells from Creative Bioarray are isolated from pancreatic tissue of pathogen-free laboratory mice. C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic pre-coated with secondary antibody.
Species
Mouse
Source
Pancreas
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System) or CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) by immunofluorescence staining or FACS. C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells are obtained from the pancreatic tissue microvasculature from C57BL/6 mice. These cells compose the inner layer of pancreatic micro-vessels and are vital for maintaining vascular homeostasis, controlling the flow of nutrients and oxygen and facilitating communication between the vascular system and surrounding pancreatic cells. Microvascular endothelial cells are important for the structural and functional integrity of the pancreatic microenvironment of the pancreas. They are involved in regulation of vascular permeability, inflammation, angiogenesis and tissue remodeling. Moreover, endothelial cell-pancreatic islet cell interactions are known to be critical in appropriate endocrine function and metabolic regulation.

C57BL/6 Mouse Pancreatic Microvascular Endothelial Cells are useful in vitro models to research pancreatic vascular biology and endothelial cellular behavior under healthy and pathological settings. These cells have been used in studies on diabetes, islet vascularization, endothelial dysfunction, inflammation, oxidative stress and pancreatic tissue damage. They are also well suited for studying endothelial responses to cytokines, growth factors, metabolic stress, and pharmaceutical substances.

miR-27b Promotes TGF-β-Induced Endothelial-Mesenchymal Transition in Pancreatic Endothelial Cells

MicroRNAs (miRNAs) are key regulators of epithelial-mesenchymal transition (EMT) and endothelial-mesenchymal transition (EndMT). In this study, miRNA microarray analysis identified that transforming growth factor-β (TGF-β) significantly upregulated miR-23b, miR-24, and miR-27b in MS-1 mouse pancreatic microvascular endothelial cells, while effects on miR-23a, miR-24-2, and miR-27a were negligible (Fig. 1a).

To determine the role of miR-27b in EndMT, they inhibited endogenous miR-27b using a locked nucleic acid (LNA) inhibitor. LNA-miR-27b effectively abolished miR-27b activity in MS-1 cells (Fig. 1b) and suppressed TGF-β-induced expression of mesenchymal markers α-SMA and SM22α (Fig. 1c). In contrast, miR-27b inhibition did not attenuate TGF-β induction of canonical Smad target genes (Smad7, Fibronectin1, PAI-1) or prevent downregulation of endothelial markers (VEGFR2, CD34).

These findings demonstrate that TGF-β selectively upregulates the miR-23b/24-1/27b cluster in MS-1 cells and that miR-27b specifically enhances mesenchymal gene expression during EndMT, independent of canonical Smad signaling. This identifies miR-27b as a positive regulator of TGF-β-driven EndMT in pancreatic endothelial cells.

miR-27b is a positive regulator of EndMT induced by TGF-β in MS-1 endothelial cells

Fig. 1. miR-27b is a positive regulator of EndMT induced by TGF-β in MS-1 endothelial cells (Suzuki HI, Katsura A, et al., 2020).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products